Related by context. Frequent words. (Click for all words.) 57 confirmatory Phase III 57 phase IIa 56 orphan designation 54 voclosporin 54 Biologics License Application 54 Phase III trials 54 alogliptin 53 PREOS 53 methylnaltrexone 53 Icatibant 53 Onsolis 53 SFDA approval 53 Phase IIa clinical trials 53 NDA submission 53 alvimopan 52 Marketing Authorization Application 52 Phase IIa trial 52 OTCQX RHHBY 52 pharmacokinetic studies 52 SPD# 52 Phenoptin 51 Complete Response 51 Marketing Authorization 51 phase IIb 51 Biologics License Application BLA 51 Phase 2b trial 51 clinical trials 51 Phase III clinical 51 NUVIGIL 51 clinical trial 51 indiplon 50 IND enabling 50 Phase 2b study 50 milnacipran 50 Phase III clinical trials 50 MBP# [001] 50 Zelrix 49 Phase IIb trial 49 linaclotide 49 velaglucerase alfa 49 Neuromed 49 TOCOSOL Paclitaxel 49 Santhera 49 Amigal 49 Indiplon 49 bucindolol 49 PF # [001] 49 Vasovist 49 Marketing Authorization Application MAA 49 OFIRMEV 49 taliglucerase alfa 49 iloperidone 49 ATryn R 49 Horizant 49 Phase 1b clinical 48 Complete Response letter 48 Abstral 48 DAVANAT ® 48 Phase 1b trial 48 Corautus 48 Phase IIb clinical 48 Pharmexa 48 Phase IIa 48 Investigational Device Exemption IDE 48 PDUFA date 48 Kevetrin 48 Phase IIb 47 confirmatory Phase 3 47 Loramyc ® 47 New Drug Application 47 sBLA 47 Phase 2a trial 47 BYDUREON 47 Orphan Drug status 47 StaphVAX 47 Vilazodone 47 NovaDel 47 Phase 2b 47 AspenBio 47 Orphan Drug designation 47 Flutiform 47 Phase Ib 47 Zerenex 47 CHMP opinion 47 Phase IIa clinical 47 maribavir 47 Cimzia ® 47 Sosei 47 teduglutide 47 calcitonin 47 topical formulation 47 CE Marking 47 Stalevo 47 Ostarine 46 Intermezzo ® 46 Phase III 46 Relistor 46 Hylenex 46 INDs 46 Dyloject 46 Reloxin